CapsoVision, Inc. CV
Rating
Rating Factors
Company Overview
CapsoVision, Inc. (NASDAQ: CV) is a medical technology company focused on capsule endoscopy systems used for gastrointestinal diagnostics. The company develops ingestible imaging capsules and related software platforms that allow physicians to visualize the gastrointestinal tract, particularly the small bowel, in a minimally invasive manner. CapsoVision operates within the broader healthcare technology and medical device industries, with its primary commercial focus centered on diagnostic imaging solutions for gastroenterology practices, hospitals, and ambulatory care providers.
The company’s principal product platform is the CapsoCam capsule endoscopy system, which combines onboard image storage, panoramic imaging capabilities, and physician review software. Revenue is primarily generated through the sale of capsule endoscopy devices, associated software, and related clinical solutions. CapsoVision’s strategic positioning has centered on differentiated capsule imaging technology designed to improve visualization and patient convenience relative to traditional wired endoscopy procedures. Public filings and company disclosures indicate that the business evolved from a specialized gastrointestinal imaging developer into a commercially focused medical device company targeting broader adoption across digestive disease diagnostics.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $4.34
- Current
- $6.92
- High
- $15.37
Valuation
Dividends and Shares
Corporate Info
Suite 250
Saratoga, CA 95070